Embedded heuristics and decision-making: In pharma, many decisions are guided by both data and heuristics (i.e., rules of ...

The industry’s intellectual property manipulations are stealing from your pockets—and limiting the benefits of the Biden ...

Some of the largest, most powerful companies in the United States are racing to finance President-elect Donald Trump's ...

To navigate this increasingly complex environment in 2025, pharma manufacturers must fundamentally rethink their models and ...

One obviously is the Trump presidency. He is the most unpredictable man and leading a $30 trillion economy, the world's most ...

An employee of a pharma company has been arrested for running a "clandestine" recreational drug manufacturing lab in ...

Japan effect funnels billions into North Carolina Pharma giant eyes Eastern NC for 420-job, billion-dollar plant Related: ...

Look no further than our top two stories of the year, and you’ll see that the GLP-1 craze and Big Pharma layoffs took center ...

Sintilimab is marketed in China as TYVYT (sintilimab injectable) and was co-developed by Innovent and Eli Lilly.

Swiss private equity firm Partners Group Holding AG is looking to rearrange its India portfolio that has quadrupled to more ...

The Indian pharmaceutical industry is poised for significant transformation by 2025, driven by technological advancements ...

Uber, Amazon and Ford are reportedly among the companies that have pledged to give $1 million to the 2025 inauguration.